DCTH Delcath Systems, Inc. - Common Stock
$16,93
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$8–$17
95% of range
Calificación del Analista
BUY
12 analysts
Precio Objetivo
$24
+42% upside
P/E (TTM)
241.9
ROE
2.5%
Margen de Beneficio Neto
3.2%
Acerca de Delcath Systems, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Leer más
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
DCTH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$16.93
Capitalización Bursátil
$587M
P/E (TTM)
241.9
BPA (TTM)
$0.07
Ingresos (TTM)
$85M
Rendimiento div.
—
ROE
2.5%
Deuda/Capital
—
Rango 52S
$8 – $17
DCTH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$85M
2016-12-31
→
2025-12-31
BPA
$0.07
2017-12-31
→
2025-12-31
Flujo de caja libre
$21M
2018-12-31
→
2025-12-31
Márgenes
3.2%
2022-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
DCTH
Mediana de Pares
P/E (TTM)
241.9
32.9
P/S (TTM) (P/V (TTM))
6.9
4.6
P/B (P/C)
5.3
3.5
Price / FCF (Precio / FCF)
28.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
DCTH
Mediana de Pares
Gross Margin (Margen Bruto)
86.2%
66.5%
Operating Margin (Margen Operativo)
0.77%
—
Net Profit Margin (Margen de Beneficio Neto)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
DCTH
Mediana de Pares
Current Ratio (Ratio corriente)
10.9
4.8
Quick Ratio (Ratio Rápido)
5.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
DCTH
Mediana de Pares
Revenue YoY (Ingresos interanuales)
129.1%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
215.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
DCTH
Mediana de Pares
DCTH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
12 analistas
- Compra fuerte 3 25,0%
- Compra 8 66,7%
- Mantener 1 8,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-18
Mediana
$22.00
Media
$24.00
← Por Debajo de Todos los Objetivos
$16.93
Mín
$21.00
Máx
$32.00
Objetivo mediano
$22.00
+29,9%
Objetivo medio
$24.00
+41,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.05%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $0.07 | $-0.09 | 0.16% |
| 31 de marzo de 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 de diciembre de 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 de septiembre de 2025 | $0.02 | $0.02 | -0.00% |
| 30 de junio de 2025 | $0.07 | $0.03 | 0.04% |
| 31 de marzo de 2025 | $0.03 | $0.02 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Balance general 25
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Balance general 23
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $85M | $37M | $2M | $3M | $4M |
| Margen Bruto % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Margen Operativo % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Beneficio neto | $3M | $-26M | $-48M | $-37M | $-26M |
| EPS Diluido | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Ratio Rápido | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $21M | $-19M | $-31M | $-25M | $-23M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 140 declarantes · $188.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 27 (0 vs trimestre anterior) | 17 (-3 vs trimestre anterior) | 40 (+6 vs trimestre anterior) | 30 (-7 vs trimestre anterior) | +1.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41 551 898 | 3 300 389 | 22,08% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $15 375 500 | 1 221 247 | 8,17% | Acciones |
| VANGUARD GROUP INC | $14 879 573 | 1 473 225 | 7,91% | Acciones |
| Propel Bio Management, LLC | $10 971 681 | 871 460 | 5,83% | Acciones |
| STATE STREET CORP | $8 552 135 | 679 280 | 4,55% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $7 923 535 | 629 139 | 4,21% | Acciones |
| ALGERT GLOBAL LLC | $7 311 114 | 580 708 | 3,89% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 130 611 | 566 371 | 3,79% | Acciones |
| Divisadero Street Capital Management, LP | $6 292 432 | 499 796 | 3,34% | Acciones |
| ExodusPoint Capital Management, LP | $4 530 940 | 359 884 | 2,41% | Acciones |
| Private Wealth Advisors, LLC | $3 913 765 | 310 863 | 2,08% | Acciones |
| Simplify Asset Management Inc. | $3 333 454 | 264 770 | 1,77% | Acciones |
| BlackRock, Inc. | $3 180 738 | 252 640 | 1,69% | Acciones |
| ADAR1 Capital Management, LLC | $2 825 007 | 224 385 | 1,50% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $2 570 450 | 204 166 | 1,37% | Acciones |
| KENNEDY CAPITAL MANAGEMENT LLC | $2 570 160 | 204 143 | 1,37% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 435 510 | 193 448 | 1,29% | Acciones |
| Ikarian Capital, LLC | $2 337 548 | 185 667 | 1,24% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 290 159 | 181 903 | 1,22% | Acciones |
| CIBC WORLD MARKET INC. | $2 054 789 | 163 208 | 1,09% | Acciones |
| Caption Management, LLC | $1 894 795 | 150 500 | 1,01% | Opción de venta |
| GOLDMAN SACHS GROUP INC | $1 885 353 | 149 750 | 1,00% | Acciones |
| Lane Generational LLC | $1 884 257 | 149 663 | 1,00% | Acciones |
| HSBC HOLDINGS PLC | $1 705 848 | 135 600 | 0,91% | Acciones |
| Man Group plc | $1 617 752 | 128 495 | 0,86% | Acciones |
| Cubist Systematic Strategies, LLC | $1 562 514 | 145 350 | 0,83% | Acciones |
| Diametric Capital, LP | $1 546 568 | 122 841 | 0,82% | Acciones |
| MORGAN STANLEY | $1 366 506 | 108 539 | 0,73% | Acciones |
| BARCLAYS PLC | $1 354 243 | 107 565 | 0,72% | Acciones |
| Caption Management, LLC | $1 259 000 | 100 000 | 0,67% | Opción de compra |
| Capital Advisors Wealth Management, LLC | $1 170 870 | 93 000 | 0,62% | Acciones |
| Jefferies Financial Group Inc. | $1 057 308 | 83 980 | 0,56% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 050 824 | 83 465 | 0,56% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 022 308 | 81 200 | 0,54% | Opción de compra |
| Stonepine Capital Management, LLC | $1 000 000 | 100 000 | 0,53% | Opción de compra |
| Caption Management, LLC | $978 243 | 77 700 | 0,52% | Acciones |
| FOX RUN MANAGEMENT, L.L.C. | $776 526 | 61 678 | 0,41% | Acciones |
| Quantbot Technologies LP | $749 860 | 59 560 | 0,40% | Acciones |
| D. E. Shaw & Co., Inc. | $728 885 | 57 894 | 0,39% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $725 864 | 57 654 | 0,39% | Acciones |
| Pale Fire Capital SE | $504 670 | 40 085 | 0,27% | Acciones |
| BANK OF AMERICA CORP /DE/ | $493 931 | 39 232 | 0,26% | Acciones |
| WOLVERINE TRADING, LLC | $479 600 | 44 000 | 0,25% | Opción de compra |
| RHUMBLINE ADVISERS | $458 822 | 36 444 | 0,24% | Acciones |
| ALPS ADVISORS INC | $441 154 | 35 040 | 0,23% | Acciones |
| EntryPoint Capital, LLC | $437 641 | 34 761 | 0,23% | Acciones |
| SEI INVESTMENTS CO | $394 936 | 31 369 | 0,21% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $378 380 | 30 054 | 0,20% | Acciones |
| Balyasny Asset Management L.P. | $358 412 | 28 468 | 0,19% | Acciones |
| Leonteq Securities AG | $348 730 | 27 699 | 0,19% | Acciones |
| CITADEL ADVISORS LLC | $334 894 | 26 600 | 0,18% | Opción de compra |
| BOOTHBAY FUND MANAGEMENT, LLC | $319 484 | 25 376 | 0,17% | Acciones |
| Xcelsior Advisor Partners LLC | $318 527 | 25 300 | 0,17% | Acciones |
| Palisades Investment Partners, LLC | $293 007 | 23 273 | 0,16% | Acciones |
| WOLVERINE TRADING, LLC | $269 666 | 24 740 | 0,14% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $239 424 | 25 800 | 0,13% | Acciones |
| MetLife Investment Management, LLC | $235 043 | 18 669 | 0,12% | Acciones |
| Bank of New York Mellon Corp | $234 942 | 18 661 | 0,12% | Acciones |
| WealthPlan Investment Management, LLC | $219 607 | 17 443 | 0,12% | Acciones |
| NOMURA HOLDINGS INC | $210 530 | 16 722 | 0,11% | Acciones |
| WOLVERINE TRADING, LLC | $209 280 | 19 200 | 0,11% | Opción de venta |
| CITADEL ADVISORS LLC | $202 699 | 16 100 | 0,11% | Opción de venta |
| CITADEL ADVISORS LLC | $189 391 | 15 043 | 0,10% | Acciones |
| SkyOak Wealth, LLC | $188 850 | 15 000 | 0,10% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188 850 | 15 000 | 0,10% | Opción de venta |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166 729 | 13 243 | 0,09% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $151 609 | 12 042 | 0,08% | Acciones |
| LANARK FINANCIAL, INC. | $150 500 | 11 954 | 0,08% | Acciones |
| CITIGROUP INC | $146 485 | 11 635 | 0,08% | Acciones |
| Invesco Ltd. | $143 790 | 11 421 | 0,08% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $140 744 | 11 179 | 0,07% | Acciones |
| Nuveen, LLC | $138 754 | 11 021 | 0,07% | Acciones |
| Vanguard Global Advisers, LLC | $133 869 | 10 633 | 0,07% | Acciones |
| Schonfeld Strategic Advisors LLC | $131 136 | 10 416 | 0,07% | Acciones |
| LPL Financial LLC | $128 859 | 10 235 | 0,07% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $126 580 | 10 054 | 0,07% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $110 729 | 8 795 | 0,06% | Acciones |
| SHERBROOKE PARK ADVISERS LLC | $109 918 | 10 883 | 0,06% | Acciones |
| Hunting Hill Global Capital, LLC | $104 716 | 11 284 | 0,06% | Acciones |
| MARSHALL WACE, LLP | $84 177 | 6 686 | 0,04% | Acciones |
| FMR LLC | $69 144 | 5 492 | 0,04% | Acciones |
| Private Wealth Advisors, LLC | $62 950 | 5 000 | 0,03% | Opción de compra |
| NEW YORK STATE COMMON RETIREMENT FUND | $60 432 | 4 800 | 0,03% | Acciones |
| OSAIC HOLDINGS, INC. | $60 254 | 4 786 | 0,03% | Acciones |
| Point72 (DIFC) Ltd | $53 931 | 5 017 | 0,03% | Acciones |
| NORTHERN TRUST CORP | $53 797 | 4 273 | 0,03% | Acciones |
| Persistent Asset Partners Ltd | $52 954 | 4 206 | 0,03% | Acciones |
| Arax Advisory Partners | $51 884 | 4 121 | 0,03% | Acciones |
| IFP Advisors, Inc | $51 657 | 4 103 | 0,03% | Acciones |
| Integrated Wealth Concepts LLC | $48 145 | 3 824 | 0,03% | Acciones |
| Ameritas Investment Partners, Inc. | $38 714 | 3 075 | 0,02% | Acciones |
| Legal & General Group Plc | $34 534 | 2 743 | 0,02% | Acciones |
| CWM, LLC | $29 343 | 3 162 | 0,02% | Acciones |
| Creative Planning | $17 777 | 1 412 | 0,01% | Acciones |
| Tripletail Wealth Management, LLC | $16 632 | 1 260 | 0,01% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14 950 | 1 611 | 0,01% | Acciones |
| AlphaQuest LLC | $14 473 | 1 433 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $13 711 | 1 089 | 0,01% | Acciones |
| Activest Wealth Management | $12 590 | 1 000 | 0,01% | Acciones |
| Geneos Wealth Management Inc. | $11 621 | 923 | 0,01% | Acciones |
Informantes de la empresa 46 insiders · 11 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 8 de mayo de 2020 C | 25 021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 8 de mayo de 2020 C | 12 851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 de noviembre de 2007 A | 3 375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 de octubre de 2023 P | 41 526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 de mayo de 2007 P | 160 375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 de diciembre de 2023 P | 100 000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 de noviembre de 2023 P | 30 000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 de noviembre de 2023 P | 40 000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 de junio de 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 de junio de 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 1 de septiembre de 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Consejero | 21 de agosto de 2023 P | 10 550 | 0 | 0 | $0 |
| Aharon Gil | Consejero | 12 de junio de 2023 A | 404 000 | 0 | 0 | $0 |
| Steven A J Salamon | Consejero | 12 de junio de 2023 A | 440 100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Consejero | 12 de junio de 2023 A | 9 309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Consejero | 19 de abril de 2022 P | 433 100 | 0 | 0 | $0 |
| Marco Taglietti | Consejero | 8 de mayo de 2020 C | 6 000 | 0 | 0 | $0 |
| William Dodge Rueckert | Consejero | 8 de mayo de 2020 C | 6 014 | 0 | 0 | $0 |
| Simon Pedder | Consejero | 1 de febrero de 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Consejero | 23 de julio de 2015 P | 205 299 | 0 | 0 | $0 |
| Harold S Koplewicz | Consejero | 10 de junio de 2015 A | 45 052 | 0 | 0 | $0 |
| Dennis Langer | Consejero | 10 de junio de 2015 A | 20 000 | 0 | 0 | $0 |
| Jonathan Lewis | Consejero | 30 de junio de 2008 A | 10 000 | 0 | 0 | $0 |
| Mark Corigliano | Consejero | 16 de abril de 2007 M | 198 176 | 0 | 0 | $0 |
| Daniel Isdaner | Consejero | 16 de abril de 2007 M | 253 668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 de mayo de 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2 de marzo de 2026 P | 342 034 | 2 | 0 | $198 447 |
| Laura Brege | — | 7 de julio de 2014 A | 11 678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 7 de julio de 2014 A | 11 678 | 0 | 0 | $0 |
| Gabriel Leung | — | 7 de julio de 2014 A | 21 485 | 0 | 0 | $0 |
| Douglas G Watson | — | 7 de julio de 2014 A | 136 664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 de noviembre de 2013 A | 54 000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 de noviembre de 2013 A | 15 000 | 0 | 0 | $0 |
| William M Appling | — | 15 de julio de 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 de marzo de 2013 A | 159 000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 de marzo de 2013 A | 17 000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 de marzo de 2013 A | 162 000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 de marzo de 2013 A | 80 944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 de junio de 2012 A | 69 534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 de marzo de 2011 A | 47 706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 1 de diciembre de 2010 A | 8 507 | 0 | 0 | $0 |
| Richard Taney | — | 10 de diciembre de 2009 A | 211 485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 de octubre de 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 de enero de 2007 X | 775 360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 de octubre de 2006 M | 180 007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 de noviembre de 2004 J | 892 649 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 17 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 presentaciones | 10 de febrero de 2026 | 9,90% | Enmienda | — | SEC |
| Persona informante no revelada | 16 de diciembre de 2022 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 27 de julio de 2022 | — | Presentación inicial | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 presentaciones | 2 de agosto de 2010 | — | Presentación inicial | — | SEC |
| Robert Ladd | 18 de octubre de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de julio de 2006 | — | Presentación inicial | Campaña de la junta directiva | SEC |
| Persona informante no revelada | 11 de julio de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 14 de junio de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 8 de junio de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 24 de mayo de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 28 de abril de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 10 de enero de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 6 de enero de 2006 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 14 de diciembre de 2005 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 10 de noviembre de 2005 | — | Presentación inicial | Campaña de la junta directiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 22 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35 814 NS | 31 de mayo de 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 97 850 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35 321 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 227 534 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21 358 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 741 852 SH | 8 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2 388 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165 177 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 13 080 NS | 30 de abril de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22 609 NS | 31 de mayo de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1 420 NS | 31 de mayo de 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 111 NS | 31 de mayo de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 38 572 SH | 8 de agosto de 2026 | Diario |
| URTY · ProShares Trust | 0,00% | 1 122 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 638 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19 222 NS | 30 de abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43 750 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304 809 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889 410 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 438 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 475 SH | 8 de agosto de 2026 | Diario |